
Sign up to save your podcasts
Or


Glaucoma is a major public health problem in the US with an estimated 3 million Americans diagnosed with the disease and as many as 120,000 who are blind as a result. Fortunately, treatments to slow the progression of glaucoma are becoming more and more available.
In this activity, Drs. Pradeep Ramulu and Ian Gaddie review what role these newer innovations play in improving outcomes for patients with glaucoma as well as the benefits and risks associated with these modalities.
By ReachMD4.3
33 ratings
Glaucoma is a major public health problem in the US with an estimated 3 million Americans diagnosed with the disease and as many as 120,000 who are blind as a result. Fortunately, treatments to slow the progression of glaucoma are becoming more and more available.
In this activity, Drs. Pradeep Ramulu and Ian Gaddie review what role these newer innovations play in improving outcomes for patients with glaucoma as well as the benefits and risks associated with these modalities.